The Protecting America from Seasonal and Pandemic Influenza Act of 2026 aims to bolster the United States' preparedness and response to influenza outbreaks, both seasonal and pandemic. The legislation focuses on improving vaccination rates, enhancing the vaccine supply chain, and advancing the development of more effective vaccines, including a universal influenza vaccine. Key provisions include the establishment of national goals for vaccine delivery, mandating that initial doses of a finished influenza vaccine be delivered within 12 weeks of identifying a new strain with pandemic potential.